Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement of Bcl-2 and p53 proteins

Journal of Neuroscience Research

Volumn 58, Issue 3, 1999, Pages 426-435

  Tieu, K ^a   Zuo, D M ^a   Yu, P H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Apoptosis; Differentiation; Neurotoxicity; SH SY5Y

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; CISPLATIN; FLUOROURACIL; OXIDOPAMINE; PROTEIN BCL 2; PROTEIN P53; RETINOIC ACID; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG TOLERANCE; GAMMA IRRADIATION; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

BENZYLAMINES; CELL DIFFERENTIATION; CELL SURVIVAL; FLUOROURACIL; GAMMA RAYS; HUMANS; NEUROBLASTOMA; NEUROTOXINS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-BCL-2; STAUROSPORINE; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033230212     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991101)58:3<426::AID-JNR8>3.0.CO;2-F     Document Type: Article

References (72)

1. Adem A, Mattsson ME, Nordberg A, Pahlman S. 1987. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res 430:235-242.
2. Akerman KEO, Scott IG, Anddersson LC. 1984. Functional differentiation of a human ganglion cell derived neuroblastoma cell line SH-SY5Y induced by a phorbol ester (TPA). Neurochem Int 6:77-80.
3. Allsopp TE, Wyatt S, Paterson HF, Davies AM. 1993. The protooncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307.
4. Barry MA, Behnke CA, Eastman A. 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353-2362.
5. Biedler JL, Helson L, Spengler BA. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
6. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:3751-3757.
7. Boix J, Llecha N, Yuste VJ, Comella JX. 1997. Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology 36:811-821.
8. Cece R, Barajon I, Tredici G. 1995. Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line. Anticancer Res 15:777-782.
9. Chakravarthy BR, Walker T, Rasquinha I, Hill IE, MacManus JP. 1999. Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells. J Neurochem 72:933-942.
10. Chen DF, Schneider GE, Martinou JC, Tonegawa S. 1997. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385:434-439.
11. Chen J, Chattopadhyay B, Venkatakrishnan G, Ross AH. 1990. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines. Cell Growth Differ 1:79-85.
12. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments]. Nature 362:849-852.
13. Cohen G, Heikkila RE. 1974. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249:2447-2452.
14. Davidoff AM, Iglehart JD, Marks JR. 1992a. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA 89:3439-3442.
15. Davidoff AM, Pence JC, Shorter NA, Iglehart JD, Marks JR. 1992b. Expression of p53 in human neuroblastoma-and neuroepithelioma-derived cell lines. Oncogene 7:127-133.
16. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. 1992. Prevention of programmed cell death of sympathetic neurons by the Bcl-2 proto-oncogene. Science 258:302-304.
17. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. 1994. Down-regulation of Bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097.
18. Hammerling U, Bjelfman C, Pahlman S. 1987. Different regulation of N-and c-myc expression during phorbol ester-induced maturation of human SH-SY5Y neuroblastoma cells. Oncogene 2: 73-77.
19. Hanada M, Krajewski S, Tanaka S, Cazals Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC. 1993. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 53:4978-4986.
20. Heikkila JE, Akerlind G, Akerman KE. 1989. Protein kinase C activation and down-regulation in relation to phorbol ester-induced differentiation of SH-SY5Y human neuroblastoma cells. J Cell Physiol 140:593-600.
21. Itano Y, Ito A, Uehara T, Nomura Y. 1996. Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectively. J Neurochem 67:131-137.
22. Jalava AM, Heikkila JE, Akerman KE. 1988. Decline in c-myc mRNA expression but not the induction of c-fos mRNA expression is associated with differentiation of SH-SY5Y human neuroblastoma cells. Exp Cell Res 179:10-17.
23. Jalava A, Heikkila J, Lintunen M, Akerman K, Pahlman S. 1992. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA). FEBS Lett 300:114-118.
24. Jalava A, Akerman K, Heikkila J. 1993. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. J Cell Physiol 155:301-312.
25. Kitamura Y, Kamoshima W, Shimohama S, Nomura Y, Taniguchi T. 1998. Nitric oxide donor-induced p53-sensitive cell death is enhanced by Bcl-2 reduction in human neuroblastoma cells. Neurochem Int 32:93-102.
26. 2+ fluxes and neuropeptide Y immunoreactivity to varicosities in SH-SY5Y human neuroblastoma cells differentiated by treatment with the protein kinase inhibitor staurosporine. Eur J Neurosci 9:140-150.
27. Lai CT, Yu PH. 1997. Dopamine-and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-dopa)-induced cytotoxicity towards cate-cholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 53:363-372.
28. Lasorella A, Iavarone A, Israel MA. 1995. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 55:4711-4716.
29. Leli U, Cataldo A, Shea TB, Nixon RA, Hauser G. 1992. Distinct mechanisms of differentiation of SH-SY5Y neuroblastoma cells by protein kinase C activators and inhibitors. J Neurochem 58:1191-1198.
30. Levine AJ, Momand J, Finlay CA. 1991. The p53 tumour suppressor gene. Nature 351:453-456.
31. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. 1993. p53 Is required for radiation-induced apoptosis in mouse thymocytes [see comments]. Nature 362:847-849.
32. Meyerson G, Parrow V, Gestblom C, Johansson I, Pahlman S. 1994. Protein synthesis and mRNA in isolated growth cones from differentiating SH-SY5Y neuroblastoma cells. J Neurosci Res 37:303-312.
33. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. 1994. Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
34. Moll UM, LaQuaglia M, Benard J, Riou G. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92:4407-4411.
35. Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M, Zambetti G. 1996. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol 16:1126-1137.
36. Myers LS, Ward JF, Tsukamoto WT, Holmes DE, Julca JF. 1965. Radiolysis of thymine in aqueous solutions: change in site of attack with change in pH. Science 148:1234-1235.
37. Pahlman S, Odelstad L, Larsson E, Grotte G, Nilsson K. 1981. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer 28:583-589.
38. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T. 1984. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14:135-144.
39. Pahlman S, Mamaeva S, Meyerson G, Mattsson ME, Bjelfman C, Ortoft E, Hammerling U. 1990. Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol Scand Suppl 592:25-37.
40. Pahlman S, Meyerson G, Lindgren E, Schalling M, Johansson I. 1991. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc Natl Acad Sci USA 88:9994-9998.
41. Parker WB, Cheng YC. 1990. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48:381-395.
42. Perez-Polo JR, Werbach Perez K, Tiffany Castiglioni E. 1979. A human clonal cell line model of differentiating neurons. Dev Biol 71:341-355.
43. Pieri A, Liguri G, Cecchi C, Degl'Innocenti D, Nassi P, Ramponi G. 1997. Alteration of intracellular free calcium and acylphosphatase levels in differentiating SH-SY5Y neuroblastoma cells. Biochem Mol Biol Int 43:633-641.
44. Preis PN, Saya H, Nadasdi L, Hochhaus G, Levin V, Sadee W. 1988. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A. Cancer Res 48:6530-6534.
45. Prince JA, Oreland L. 1997. Staurosporine differentiated human SH-SV5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence. Brain Res Bull 43:515-523.
46. Recio-Pinto E, Ishii D. 1984. Effects of insuline, insuline-like growth factor-II and nerve growth factor on neunte outgrowth in cultured human neuroblastoma cells. Brain Res 302:323-334.
47. Reed JC. 1996. Bcl-2 and the regulation of programmed cell death in cancer. In: Sluyser M, editor. Apoptosis in normal development and cancer. Bristol: Taylor and Francis, Inc. p 127-169.
48. Reed JC. 1994. Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6.
49. Reed JC, Kitada S, Takayama S, Miyashita T. 1994. Regulation of chemoresistance by the Bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann Oncol 5(Suppl 1):61-65.
50. Roberts JJ, Thomson AJ. 1979. The mechanism of action of antitumor platinum compounds. Progr Nucleic Acid Res Mol Biol 22:71-133.
51. Ronca F, Chan SL, Yu VC. 1997. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine induces apoptosis in human neuroblastoma cells, SH-SY5Y, through a p53-dependent pathway. J Biol Chem 272:4252-4260.
52. Rossino P, Defilippi P, Silengo L, Tarone G. 1991. Up-regulation of the integrin alpha 1/beta 1 in human neuroblastoma cells differentiated by retinoic acid: correlation with increased neurite outgrowth response to laminin. Cell Regul 2:1021-1033.
53. Scholes G, Weiss J, Wheeler CM. 1956. Formation of hydroperoxides from nucleic acids by irradiation with X-rays in aqueous systems. Nature 178:157.
54. Scott IG, Akerman KE, Heikkila JE, Kaila K, Andersson LC. 1986. Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells. J Cell Physiol 128:285-292.
55. Shchepotin IB, Soldatenkov V, Buras RR, Nauta RJ, Shabahang M, Evans SR. 1994. Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia. Anticancer Res 14:1027-1031.
56. Sidell N. 1982. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68:589-596.
57. Sonnenfeld KH, Ishii DN. 1982. Nerve growth factor effects and receptors in cultured human neuroblastoma cell lines. J Neurosci Res 8:375-391.
58. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
59. Spinelli W, Sonnenfeld KH, Ishii DN. 1982. Effects of phorbol ester tumor promoters and nerve growth factor on neunte outgrowth in cultured human neuroblastoma cells. Cancer Res 42:5067-5073.
60. Tahayato A, Lefebvre P, Formstecher P, Dautrevaux M. 1993. A protein kinase C-dependent activity modulates retinoic acid-induced transcription. Mol Endocrinol 7:1642-1653.
61. Takahashi T, Maruyama W, Deng Y, Dostert P, Nakahara D, Niwa T, Ohta S, Naoi M. 1997. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. J Neural Transm 104:59-66.
62. ++-dependent protein kinase. Biochem Biophys Res Commun 135:397-402.
63. Toselli M, Tosetti P, Taglietti V. 1996. Functional changes in sodium conductances in the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. J Neurophysiol 76:3920-3927.
64. Tosetti P, Taglietti V, Toselli M. 1998. Functional changes in potassium conductances of the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. J Neurophysiol 79:648-658.
65. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. 1985. Involvement of the Bcl-2 gene in human follicular lymphoma. Science 228:1440-1443.
66. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pelletier J, Gros P. 1993. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53:5269-5273.
67. Vogelstein B, Kinzler KW. 1992. p53 Fnction and dysfunction. Cell 70:523-526.
68. Weiler R, Meyerson G, Fischer Colbrie R, Laslop A, Pahlman S, Floor E, Winkler H. 1990. Divergent changes of chromogranin A/secretogranin II levels in differentiating human neuroblastoma cells. FEBS Lett 265:27-29.
69. Willets JM, Lambert DG, Griffiths HR. 1993. Suitability of B65 and SH-SY5Y neuroblastoma cells as models for 'in vitro' neurotoxicity testing. Biochem Soc Trans 21:452S.
70. Willets JM, Lambert DG, Lunec J, Griffiths HR. 1995. Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells. Eur J Pharmacol 293:319-326.
71. Yonish Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347.
72. Yu PH, Davis BA, Fang J, Boulton AA. 1994. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus. J Neurochem 63:1820-1828.